Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6229 matches for

Vaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured £20 million in Series A financing.

Doctor of Medicine

Applied Cancer Science MSc

Radiobiology MSc

Medical Physics with Radiobiology MSc

Genomic Medicine

MSc in Modelling for Global Health

Applied Digital Heath

Inflammatory and Musculoskeletal Disease

The Kennedy Trust for Rheumatology Research-funded OxKen programme will fully fund 4 Oxford University medical students each year from 2021-5 to undertake DPhils in the Medical Sciences Division in the fields of musculoskeletal disease, inflammation and immunology.

MSc Medical Education

DPhil Biomedical Sciences (NIH OxCam)

Computational Discovery

The DPhil in Computational Discovery is a multidisciplinary programme spanning projects in Advanced Molecular Simulations, Machine Learning and Quantum Computing to develop new tools and methodologies for life sciences discovery.

DPhil in Cancer Science

The DPhil in Cancer Science programme is unique and distinctive in offering integrated training across the following themes: Immunity, Infection & Inflammation; DNA Damage Response & Radiation Biology; Cancer Genetics & Epigenetics; and Cancer Big Data. It builds on Oxford’s outstanding research record in these areas, spanning both the University and Hospital Trust.

Precision Cancer Medicine MSc

Translational Health Sciences MSc

Precision Medicine MSc

Translational Health Sciences MSc

Clinical and Therapeutic Neuroscience MSc

Clinical Trials MSc

Chemistry in Cells: New Technologies to Probe Complex Biology and Medicine

Paediatric Infectious Diseases PGDip

Load More

Similar stories

The women founders contributing to Oxford’s spinout success

More spinout companies are created by the University of Oxford than any other UK University and an increasing number of their founders and senior leaders are women.

NICE recommends digital mental health technologies from Oxford

Two digital tools were recommended for use in the NHS to help children and young people with symptoms of anxiety or low mood.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

Significant scale-up investment for three Oxford spinouts

Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.

Oxford Innovation Society celebrates pioneering biomedical research and innovation

Last month the Oxford Innovation Society (OIS) hosted an event at Pembroke College which celebrated some of the pioneering translational research and innovation coming out of the University’s Medical Sciences Division.

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.